Ms. Shunee Yee is the President and CEO of CSOFT International, a leading global communications and localization company. Responsible for its organic growth from a start-up in a two-bedroom apartment, to becoming an industry leader, Yee oversees CSOFT’s operations across 16 offices and 3 continents.
Professor Victoria Elegant
Professor Elegant is a physician who joined the pharmaceutical industry after postgraduate training in obstetrics and gynecology in the UK. She has held positions in global drug development, medical affairs, regulatory affairs and drug safety in Japan, Australia, Europe and Asia Pacific. She joined Amgen in October 2016 and is Vice-President, JAPAC Regional Medical Head, based in Hong Kong.
Prior to Amgen, Dr. Elegant was the Vice-President, Regulatory and Medical Affairs, APAC, based in Shanghai for Baxter, and Vice President, Medical Affairs, Asia/ANZ for Baxalta.
Professor Elegant is actively engaged in the training and education of physicians in the healthcare industry. She was involved with establishing the first postgraduate training course for pharmaceutical physicians in Australia. Dr. Elegant is a Fellow of the Faculty of Pharmaceutical Medicine, a member of the FPM International Committee, and is currently working on training programs in the Asia-Pacific region. She is on the Board of Studies for the Masters in Pharmaceutical Medicine, UNSW. She is a founding member of the China Medical Affairs Network. She is on the board of the Medical Affairs Professional Society, and is Adjunct Professor, Faculty of Medicine, University of New South Wales, Sydney Australia.
Professor Elegant is passionate about promoting diversity and inclusion, especially in supporting women leadership. She was involved in Building Talent Edge, a Catalyst Award-winning program supporting women in Baxter Healthcare and leading to a 50:50 men:women ratio at the senior manager level and above across the Asia-Pacific region.
Dr. CJ Li
Li Chenjian is a principal investigator at the IDG McGovern Institute for Brain Research and Associate Dean of the School of Life Sciences at Peking University. His research in neuroscience and drug development has led to significant insights into the mechanisms of neurodegenerative diseases.
Senior Practice Lead & Executive Director, CSOFT Health Sciences
Entering the healthcare market in 2010, Di first worked for BGI (Beijing Genomics Institute), one of the largest biotechnology firms in China. Her work at BGI took her to Belgium and Germany as the Business Development Manager, calling on clinical institutions, medical schools, and pharmaceutical companies.
Ned DaiRegulatory Specialist, NMPA Regiatration and Approval
Bruce WangChief Strategist, China Market Access
Dr. Wang entered the field of translational research in 2013. He headed the Foshan Industrial Technology Research Institute of the Chinese Academy of Sciences’ pharmaceutical project and established strong commercialization partnerships with the Chinese Academy of Sciences and Peking University.
Dr. Wang holds a degree in Pharmacy from the Peking University Health Science Center and was Vice Chairman of the Student Union at the Center.